Tri-Con 2024 San Diego | Cambridge Innovation Institute | 26 March 2024 | Hilton San Diego Bayfront, 1 Park Blvd, San Diego, CA 92101, USA

Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including Multi-Cancer Early Detection and Minimal Residual Disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024

2024 Speakers

Edward Abrahams
PhD, President, Personalized Medicine Coalition

Alexey Aleshin, MD
General Manager, Oncology and Early Cancer Detection; CMO, Natera, Inc.

Michael J. Alkire
President and CEO, Premier, Inc.

Jim Almas, MD
Vice President and National Medical Director, Clinical Effectiveness, LabCorp

Ashley Arthur
Vice President, Head of Market Access, GeneDx

Mara G. Aspinall
Partner, Illumina Ventures; Professor of Practice, Arizona State University; Editor, Sensitive & Specific: The Testing Newsletter

Michael Astion, MD
PhD, Regional Medical Director & Professor, Laboratory Medicine and Pathology, Seattle Children's Hospital and the University of Washington

Esther Babady, PhD, D(ABMM), FIDSA, FAAM
Chief, Clinical Microbiology Service, Memorial Sloan Kettering Cancer Center

Peter Bach, MD
CMO, Delfi Diagnostics

Lourdes Barrera, PhD
Executive Director, Global Medical Affairs, Merck

J. Carl Barrett, PhD
Professor, University of North Carolina

Anne Beaubrun, PhD
Vice President, Global Health Economics & Outcomes Research, Cepheid

Jonathan Beer
Senior Director, Diagnostic Sciences, Bristol Myers Squibb

Tomasz Beer, MD, FACP
Chief Medical Officer and VP, Multi-Cancer Early Detection, Exact Sciences

Paul Beresford
Vice President and General Manager, CDx, Agilent Technologies

Gregory J. Berry, PhD
Associate Professor, Pathology & Cell Biology, Columbia University Vagelos College of Physicians and Surgeons

Manoj Bhasin, PhD
Associate Professor, Pediatrics and Biomedical Informatics, Emory School of Medicine; Associate Professor, Biomedical Engineering and Bioinformatics, Georgia Tech

Gabriel Bien-Willner, MD, PhD
Medical Director, MolDx, Palmetto GBA

Clarisa Blattner
Senior Director, Revenue and Payor Optimization, XiFin, Inc.

Rose Brannon
Director of Clinical Bioinformatics, Memorial Sloan Kettering Cancer Center

Stacey Brown
Market Access Lead, Optum Genomics

Atul Butte, PhD
Chan & Zuckerberg Distinguished Professor & Director, University of California, San Francisco

Jonathan M. Carlson, PhD
Managing Director, Microsoft Health Futures

Lon Castle, MD
Associate CMO, Precision Medicine, EviCore

Charles Chiu, MD, PhD
Professor, Laboratory Medicine and Medicine/Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, UCSF Clinical Microbiology Laboratory, UCSF School of Medicine

Ezra Cohen, MD
CMO, Oncology, Tempus Labs, Inc.

Christopher Conn, PhD
Global Director, Clinical Biomarkers & Diagnostics, Diagnostics Strategy Lead, Amgen

Dana Connors, MSc, PMP
Director, Cancer Research Partnerships, Foundation for the National Institutes of Health

Robert Cook, Ph.D.
Senior Vice President, Research & Development, Castle Biosciences

Ahmet Coskun, PhD
Assistant Professor, Biomedical Engineering, Georgia Institute of Technology

Stacey DaCosta Byfield, PhD, MPH
Vice President, Genomic Health Economics and Outcomes Research, Optum Genomics

Partha Das, MD
Global Medical Director, Precision Medicine & Pipeline, Janssen Oncology

Kevin Davies, PhD
Executive Editor, The CRISPR Journal; Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing

Yanxiang Deng, PhD
Assistant Professor, Pathology & Lab Medicine, University of Pennsylvania

Lauri Diehl, PhD
Executive Director, Research Pathology, Gilead Sciences

Nicholas C. Dracopoli, PhD
CSO, Delfi Diagnostics

James Eberwine, PhD
Elmer Holmes Bobst Professor, Systems Pharmacology and Translational Therapeutics; Co-Director, Penn Program in Single Cell Biology; Co-Director, Penn Center for Subcellular Biology, University of Pennsylvania Perelman School of Medicine

Eli Glezer, PhD
CSO & Founder, Singular Genomics

Helmy Eltoukhy, PhD
Co-CEO, Guardant Health

Ruth Etzioni, PhD
Professor, Public Health Sciences, Fred Hutch Cancer Center

Lauren Feldman
Vice President and Head, Value, Access, and Pricing, ADVI

Douglas Flora, MD
Executive Medical Director, Oncology Services, St. Elizabeth’s Healthcare; Editor-in-Chief, AI in Precision Oncology Journal

Thomas Fouqueau, PhD
R&D Team leader, R&D, Meridian Bioscience

John L. Fox, MD
Senior Medical Director for the Americas, Illumina, Inc.

Mark Gardner, MBA
Senior Vice President, Molecular Genomics and Oncology, Quest Diagnostics

Lana Garmire, PhD
Associate Professor, Computational Medicine & Bioinformatics, University of Michigan

C. Taylor Gilliland, PhD
Senior Advisor for Innovation Programs, Office of the Director, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

Matthew Goldberg, M.D., FAAD
Senior Vice President, Medical, Medical, Castle Biosciences

Benjamin Good, PhD
Vice President Artificial Intelligence, Data Science, Rosalind, Inc.

Alex Greninger, MD, PhD
Assistant Professor, Laboratory Medicine, University of Washington

Gulfem Guler, PhD
Senior Director, Translational Research, ClearNote Health

Jill Hagenkord, MD
CMO, Optum Genomics

Nicholas Halzack, MPH
Director, Health Policy, Roche Diagnostics

Sam Hanash, MD, PhD
Director, Red & Charline McCombs Institute; Evelyn & Sol Rubenstein Distinguished Chair, Cancer Prevention; Professor, Clinical Cancer Prevention-Research, Translational Molecular Pathology, University of Texas MD Anderson Cancer Center

Chris M. Hartshorn, PhD
Chief, Digital & Mobile Technologies Section—CTSA Program, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH)

Bethany Hills Grois, JD, MPH
Vice Chair, FDA Regulatory, DLA Piper LLP

Dave S. B. Hoon, PhD
Director, Translational Molecular Medicine and Genome Sequencing, Saint John's Cancer Institute

Damon Hostin
Lead, Health System Market Access, Illumina, Inc.

William L. Hwang, PhD
Instructor, Radiation Oncology, Massachusetts General Hospital

Sanjay Juneja, MD
Hematologist & Medical Oncologist, Mary Bird Perkins Cancer Center

Evan T. Keller, DVM, PhD
Professor of Urology and Pathology, School of Medicine, University of Michigan; Director, Single Cell Spatial Analysis Program

Larry Kessler, ScD
Professor, Health Systems and Population Health, University of Washington; Deputy Chair, MCED Consortium

Sean Khozin, MD, MPH
Research Affiliate, Massachusetts Institute of Technology; Founder, Phyusion

Eric Klein, MD
Distinguished Scientist, GRAIL, Inc.

Michael E. Klepser, PharmD, FCCP, FIDP
Professor, Ferris State University College of Pharmacy

Nikolaos Kourtis, PhD
Scientist, Regeneron

Razelle Kurzrock, MD
Professor, Medicine, Associate Director, Clinical Research, Linda T. and John A. Mellowes Endowed Chair of Precision Oncology, Medical College of Wisconsin; CMO, Worldwide Innovative Network (WIN) for Personalized Cancer Therapy

Kathyrn Lang
Senior Vice President, Real-World Data and Analytics, Freenome

Adrian Lee, PhD
Professor, Pharmacology & Chemical Biology, University of Pittsburgh

Elyse LeeVan, MD, MPH
Program Officer, Cancer Screening Research Network, National Cancer Institute, National Institutes of Health

Lauren Leiman
Executive Director, BLOODPAC Consortium

Jochen Lennerz, MD, PhD
Director, Center for Integrated Diagnostics, Massachusetts General Hospital; Associate Professor, Pathology, Harvard Medical School

Imanuel Lerman, MD, MSc
Professor, Electrical and Computer Engineering, Anesthesiology, University of California, San Diego

Jing Li, PhD
R&D Scientific Manager, Research and Development, Streck

Yuhwa Lo, PhD
Professor, Electrical & Computer Engineering, University of California, San Diego

Arturo Loaiza-Bonilla, MD
Co-Founder & CMO, Massive Bio, Inc.

Yuan Luo, PhD
Chief AI Officer & Associate Professor, Northwestern University Feinberg School of Medicine

Sangeetha Mahadevan, PhD
Senior Research Scientist, Gilead Sciences

Sonya Makhni, MD
Medical Director, Mayo Clinic Platform

Elizabeth M. Marlowe, PhD
D(ABMM), Executive Scientific Director, Head R&D Infectious Diseases & Immunology, Quest Diagnostics

Jean-Francois Martini, PhD
Diagnostics & Translational Lead, Global Product Development – Oncology and Rare Diseases, Pfizer Inc.

John Mattison, MD
Operating Partner/Chief Medical Information Officer, Arsenal Capital Partners

Larissa May, MD, MSPH, MBA
Professor, Emergency Medicine; Director, Emergency Medicine Innovation and External Partnerships; Assistant Clinical Ventures Officer, UC Davis Health

Geoff McCleary
Vice President, Global Connected Health, Capgemini

Jennifer McClure
Global Portfolio Manager, Custom Antibodies, MilliporeSigma, Diagnostics and Regulated Materials, MilliporeSigma

Molly McGinniss
Senior Director, Population Genomics and Precision Medicine, Genome Medical

Steve Miller, MD, PhD
CMO, Delve Bio

Michael Montalto, PhD
CSO, PathAI, Inc.

Shawn Mulvaney, PhD
Health Science Administrator, Bioanalytical Sensors Portfolio, National Institute of Biomedical Imaging and Bioengineering

Ronald Myers, PhD
Professor, Division of Population Science, Medical Oncology, Thomas Jefferson University

Rainer Ng, PhD
Head, Technology Development, Baebies, Inc.

James Nichols, PhD, DABCC, FADLM
Professor of Pathology, Microbiology, and Immunology; Medical Director, Clinical Chemistry and POCT, Vanderbilt University School of Medicine

Courtney Noah, PhD
Vice President, Scientific Affairs, BioIVT

Lesley Northrop, PhD
Chief Diagnostic Officer, Everly Health

Andrea O’Hara, Ph.D
Strategic Technical Specialist, Azenta Life Sciences

Jai Pandey, PhD
Head, Global Device Regulatory IVD/CDx and Digital Health, Sanofi

Alpa V. Patel, PhD
Director, Cancer Prevention Study, American Cancer Society

Michael Pellini, MD
General Partner, S32

Scott Penberthy, PhD
Managing Director, Applied AI, Google Cloud

Brad Perkins, MD
CMO, Karius, Inc.

Gary Pestano, PhD
Chief Development Officer, Biodesix, Inc.

Jasmine Plummer, PhD
Associate Member, Developmental Neurobiology, St Jude Children's Research Hospital

Colles Price, Phd
Principal Scientist, Takeda

Daryl Pritchard, PhD
Senior Vice President, Science Policy, Personalized Medicine Coalition

Oscar Puig, PhD
Vice President, Translational Medicine & Diagnostics, Nucleai

Jennifer Quigley
Senior Director, Global Precision Diagnostics, Novartis

Bruce Quinn, MD, PhD
Principal, Bruce Quinn Associates, LLC

Rajiv Raja, PhD
Executive Director, Translational Research and Innovation, Precision Medicine, Oncology R&D, GSK

Stuart C. Ray, MD
Professor of Medicine (Infectious Diseases) and Oncology, Vice Chair of Medicine for Data Integrity and Analytics, Johns Hopkins University School of Medicine

Sean Roenspie
Senior Scientist, Custom Antibodies Lead, MilliporeSigma, Diagnostics and Regulated Materials, MilliporeSigma

Sandra Waugh Ruggles, PhD
Director, Policy Research, Stanford Byers Center for Biodesign; President, Summit Rock Strategy

Chloe Ryder
Liquid Biopsy Clinical Application Product Manager, Product Management, SOPHiA GENETICS

Hakan Sakul, PhD
Owner and President, Precision Dx Strategies, Inc.

Virginia Savova, PhD
Senior Director & Global Head, Single Cell Biology, Sanofi

Howard I. Scher, MD
Head of Biomarker Development Program, Member and Attending Physician, Department of Medicine, Memorial Sloan Kettering Cancer Center

Brock Schroeder, PhD
Vice President, Market Access, Illumina, Inc.

Shaoline Sheppard
Senior Data Scientist, Data Science, Scailyte

Anthony N. Sireci, MD
Senior Vice President, Clinical Biomarkers & Diagnostics Division, Loxo@Lilly

Gregory Sommer, PhD
Scientific Discipline Director, Alternative Sample Collection, Labcorp

Anil K. Sood, PhD
Professor and Vice Chair for Translational Research, Departments of Gynecologic Oncology and Reproductive Medicine; Co-Director, Center for RNA Interference and Non-Coding RNA, MD Anderson Cancer Center

Sudhir Srivastava, PhD
Chief, Cancer Biomarkers Research Group, NIH NCI

Eric Stahlberg, PhD
Director, Cancer Data Science Initiatives, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Rockville, Maryland, USA

Kari Stefansson, MD, PhD
CEO, deCODE genetics

Ester Stein
Director, Corporate Reimbursement, Government Affairs, Abbott Laboratories

Andrea L. Stevens, PhD
Director, Precision Medicine Access Strategy, Janssen Pharmaceuticals, Inc.

Timothy Sweeney, PhD
Co-Founder & CEO, Inflammatix, Inc.

Sarah Thibault-Sennett, PhD
Senior Director, Reimbursement Policy, American Clinical Lab Association

Eric Topol, MD
Founder and Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research

Nam K. Tran, PhD
Professor, Pathology and Laboratory Medicine, University of California, Davis

Pankaj Vats, PhD
Senior Bioinformatics/Genomics Scientist, NVIDIA

Jithesh Veetil, PhD
Senior Program Director, Digital Health & Technology, Medical Device Innovation Consortium

Jeffrey Venstrom, MD
CMO, GRAIL

John Warren
Owner and Principal Consultant, Gettysburg Healthcare Consulting, LLC

Keith Wharton, Jr, MD, PhD
Global Medical Affairs Leader - Pathology, Roche Diagnostics Solutions

Julie Wiedower
Director, Medical Affairs, Managed Care, Guardant Health

Stephen T. C. Wong, PhD
Chair & Professor, Houston Methodist Hospital and Weill Cornell Medical College

Christopher W. Woods, MD, MPH
Professor, Medicine, Global Health & Pathology, Duke University

Alexander Xu, PhD
Instructor, Biomedical Sciences, Cedars Sinai Medical Center

Paul Yager, PhD
Professor, Department of Bioengineering, University of Washington

Shaun Yang, PhD
Associate Clinical Professor, Director, Molecular Microbiology and Pathogen Genomics Laboratory, University of California, Los Angeles

Eugene Yeo, PhD, MBA
Professor, Cellular and Molecular Medicine, University of California, San Diego; Founding Member, Institute for Genomic Medicine

Hoi-Ying Elsie Yu, PhD
System and Core Laboratory Director, Chemistry, Toxicology and Point-of-Care Testing, Geisinger Health System

Noah Zimmerman, Phd
Vice President, Translational Science, Tempus

Maryellen de Mars, PhD
Program Director, Clinical Diagnostics, Medical Device Innovation Consortium

2024 Sponsors

CORPORATE SPONSORS:
• Agilent
• Azenta Life Science
• Battelle
• Biosedix
• Bio IVT
• Exact Science
• Invetech
• Meridian Bioscience
• Millipore Sigma
• Pre Analytix
• Qiagen
• Rosalind
• Scailyte
• Singular Genomics
• Sophia Genetics
• Streck

CORPORATE SUPPORT SPONSORS:
• ABS
• Acela Bio
• Axxin
• Beaufort
• Biolyph
• Bioneer
• Bio Spyder
• Bioview
• Chroma
• Cureline
• Cytiva
• Firalis Molecular Precision
• Gore
• HKSTP
• Indigo
• IProcess
• KYAN Technologies
• Luminex BioTechne
• Natech Plastics
• Nor Gen Biotek Corp.
• Omega Bio-Tek
• Proscia
• Proteome Sciences
• Quansys Biosciences
• Reference Medicine
• 3D Genomics
• Vantiva
• Veranex
• Zeon